AngioDynamics (ANGO) Beats By 2c; Guides
More News related to ANGO
- Caris & Company Downgrades AngioDynamics (ANGO) to Above Average
- AngioDynamics (ANGO) Reports Q2 In-Line; Guides
- AngioDynamics Reports Financial Results for Fiscal 2009 Second Quarter
- Trading Radar for 1/6: Global Payments (GPN), Acuity (AYI), Xyratex (XRTX), Finish Line (FINL), AngioDynamics (ANGO) Report; Factor Orders, ISM Services Due
- First Lung Lesion and First Lymph Node Metastasis Treated With AngioDynamics' IRE Technology at Australia's The Alfred Hospital
More News related to Earnings
- Standard & Poor's Places Alcoa's (AA) Ratings On Watch Negative
- Analyst Remains on Apple Sidelines Following Uneventful Macworld (AAPL); Won't Get Constructive til Mid-$70's
- Cramer Makes Verizon (VZ) a Top 5 Pick for '09
- Chinese Internet Crackdown Marks Trouble for Baidu (BIDU) in '09; Pali Reiterates Sell
- Citi Reiterates a 'Hold' on Pfizer (PFE), M&A Needed to Reposition the Company
AngioDynamics (Nasdaq: ANGO) reports Q4 EPS of $0.19, 2 cents better than the analyst estimate of $0.17. Revenues for the quarter were $46.8 million, versus the consensus of $45.60 million.
Sees FY09 GAAP EPS about 55c (including 13 cent item) versus consensus estimates of 64 cents
Sees FY09 revenues $205-$210 million versus $201.3 million
Related Categories
EarningsGuidance
Stocks Mentioned
-1.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
